I

Insmed

Develops therapies for rare diseases

Director Bioprocess Development - Biologics Research

Bioprocess & BiomanufacturingUpdated on Nov 13
Full-timeLebanon, NH, USA

About the Job

Requirements

  • A PhD in chemical engineering, biochemical engineering, biology, or a related field with at least five years of industry experience, or an M.S. with at least eight years of industry experience.
  • Demonstrated biologics process development experience in biotechnology or pharmaceutical settings.
  • Deep experience in both upstream and downstream bioprocess development.
  • Expertise in early- to late-stage preclinical CMC for biotherapeutic development candidates.
  • Hands-on experience with microbial expression systems, specifically E. coli, and mammalian expression systems; bench-scale bioreactor operation optimization; protein purification and characterization workflow optimization; scalable processes; and construction and optimization of commercial microbial and mammalian expression strains.
  • A successful track record of technology transfer to technical operations groups and/or contract development and manufacturing organizations.
  • Ability to create structure while remaining agile and to work hands-on while operating strategically.
  • A track record of building and leading teams and/or functional groups.
  • Experience managing multiple programs in a fast-paced, research-driven environment.

Responsibilities

  • Lead the design, buildout, and execution of upstream and downstream capabilities within the Biologics Research organization.
  • Build, lead, and mentor a high-performing research bioprocess development team and establish a collaborative, accountable, and scientifically rigorous team culture.
  • Set priorities and allocate resources across multiple concurrent programs.
  • Design and oversee the buildout of research bioprocess development laboratories.
  • Define equipment strategy and select platforms for microbial and mammalian upstream processing, and downstream purification workflows including chromatography and filtration.
  • Implement scalable, fit-for-purpose technologies aligned with early-stage and preclinical needs.
  • Provide subject matter expertise in recombinant protein expression in bacterial and mammalian systems, cell culture process development, media optimization, scale-up strategies, and protein purification processes including flocculation, tangential flow and depth filtration, buffer exchange, and affinity, ion exchange, and mixed mode chromatography.
  • Develop robust, reproducible processes suitable for preclinical material generation and establish platform approaches and best practices for rapid program advancement.
  • Contribute directly to experimental design, experimentation, troubleshooting, and data interpretation; lead or support critical experiments, particularly during early laboratory setup and high-priority programs.
  • Develop and review protocols, reports, and technical documentation.
  • Partner with Discovery, Analytical, Technical Operations, and Preclinical Development teams.
  • Support multiple biologics programs across modalities, including enzymes, antibodies, and fusion proteins, and align bioprocess strategies with program timelines and CMC expectations.
  • Provide input into candidate selection based on developability and manufacturability.
  • Establish processes and documentation to support transition into formal CMC development.
  • Collaborate with external partners or internal CMC teams on technology transfer and scale-up.
  • Ensure early processes are designed with downstream manufacturability in mind.

Desired Qualifications

  • Scale-up knowledge for bioreactor operations.
  • Experience building laboratories and selecting capital equipment.
  • Exposure to early GMP considerations.
  • Familiarity with biologic modalities including enzymes, monoclonal antibodies, bispecifics, engineered proteins, and half-life extension technologies.

About the Company

Insmed

Develops therapies for rare diseases

Insmed focuses on developing and delivering therapies for serious and rare diseases. Its products come from a pipeline of clinical trials and approved treatments, sold to patients in global markets with offices in Bridgewater, NJ, Europe, and Japan. The company’s work combines research and development, regulatory approvals, and commercialization to bring therapies from discovery to patients. Insmed differentiates itself by addressing unmet medical needs in rare diseases and maintaining a global infrastructure that supports development, approval, and patient access. The goal is to improve patient outcomes by providing effective treatments for conditions with limited existing options.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Bridgewater Township, New Jersey
Founded
1988

Recently Posted Jobs

Explore more opportunities at Insmed

See more jobs